Clinical trial
VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
NCT07725562
Study timeline
Study start (actual)2026-07-17Date precision: day
Registry last updated2026-09-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Disease (PD)unresolved
Interventions
VG081821ACDRUG
PlaceboOTHER
Sponsors & collaborators
Zhejiang Vimgreen Pharmaceuticals, Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07725562 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.